Related references
Note: Only part of the references are listed.Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNFα and rituximab
Stefan Vordenbaeumen et al.
CLINICAL RHEUMATOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Update on Immunologic Therapy With Anti-CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
Katharina C. Kaehler et al.
SEMINARS IN ONCOLOGY (2010)
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
K. J. Carpenter et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Autoimmune Inflammatory Myopathy after Treatment with Ipilimumab
Gary Hunter et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2009)
Ipilimumab: controversies in its development, utility and autoimmune adverse events
Jeffrey Weber
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Anti-CTLA4 Monoclonal Antibody Induced Sarcoidosis in a Metastatic Melanoma Patient
A. Eckert et al.
DERMATOLOGY (2009)
Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma
Luis H. Camacho et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sarcoidosis During Anti-Tumor Necrosis Factor-alpha Therapy: No Relapse After Rechallenge
Deborah van der Stoep et al.
JOURNAL OF RHEUMATOLOGY (2009)
Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient
Katharina C. Kaehler et al.
MELANOMA RESEARCH (2009)
Anti-CTLA4 Antibody-Induced Lupus Nephritis.
Fouad Fadel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases
Claire Immediato Daien et al.
RHEUMATOLOGY (2009)
α-CTLA-4 mAb-associated panenteritis -: A histologic and immunohistochemical analysis
Darryl A. Oble et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Safety of tremelimumab (CP-675,206) in patients (pts) with advanced cancer
N. Wallis et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Neoplastic and non-neoplastic proliferative disorders of the perirenal space: Cross-sectional imaging findings
Venkateswar R. Surabhi et al.
RADIOGRAPHICS (2008)
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
Stephanie G. Downey et al.
CLINICAL CANCER RESEARCH (2007)
Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis
James C. Yang et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Cytotoxic T-Lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer
JA Blansfield et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C - A case report and review of the literature
EA Hurst et al.
ARCHIVES OF DERMATOLOGY (2005)